NCT01445535 2021-11-03Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell LymphomasNational Institutes of Health Clinical Center (CC)Phase 1 Completed15 enrolled 18 charts
NCT00787527 2014-09-09SAHA + CHOP in Untreated T-cell Non-Hodgkin's LymphomaM.D. Anderson Cancer CenterPhase 1/2 Completed14 enrolled 8 charts